Heart attack patients who were treated with the low-cost beta blocker metoprolol on their way to the hospital had 20% less heart tissue damage than those who received a placebo, according to a study in the journal Circulation. Patients with less heart tissue damage are less likely to require an implantable defibrillator and other expensive treatments or need long hospitalization, researchers said.
Beta blocker may help reduce heart attack damage, study finds
SmartBrief Job Listings for Health Care
|NGS Provider Enrollment Rep||
National Government Services - WellPoint
|Program Manager II||
Tufts Health Plan/Network Health
|Director, Medicare Advantage/Medicare Part D Focus||
|Chief, Product Review Branch||
FDA/Center for Biologics Evaluation and Research
|Silver Spring, MD|
|Director of Clinical Research||
Regenesis Biomedical, Inc.